Edition:
India

People: China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK)

0512.HK on Hong Kong Stock

5.27HKD
8:41am IST
Change (% chg)

HK$0.34 (+6.90%)
Prev Close
HK$4.93
Open
HK$4.98
Day's High
HK$5.35
Day's Low
HK$4.81
Volume
2,326,900
Avg. Vol
2,250,134
52-wk High
HK$5.35
52-wk Low
HK$1.57

Xie, Guofan 

Mr. Xie Guofan is the Director of Grand Pharma (China), a subsidiary of China Grand Pharmaceutical and Healthcare Holdings Ltd. since 1994. Mr Xie is responsible for overseeing entire operations and management of Grand Pharm (China), he has over 30 years of experience in corporate management and pharmaceutical manufacturing. Mr Xie holds a practicing pharmacist license in the PRC.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Chengwei Liu

50,000

Yan Shao

1,516,000

Bo Hu

50,000

Zhanqi Niu

--

Yonghua Feng

--

Xiaofeng Shi

--
As Of  31 Dec 2014